Evolent Health
EVH· Services· Fiscal year ends in December
CEO pay in FY2025
Seth Blackley is the CEO of Evolent Health and was paid $14.2M in FY2025 (Dec), up 28%.
PayNo stock prices for these years
Executives5
See all- 1Seth BlackleyChief Executive OfficerFY2025
- 2Daniel McCarthyPresidentFY2025
- 3John JohnsonFormer Chief Financial Officer; Chief Strategy OfficerFY2025
- 4Jonathan WeinbergGeneral CounselFY2025
- 5Emily RaffertyFormer Chief Operating Officer; EVP, Customer SuccessFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allEvolent Health paid its 5 named executives $34.3M in total in FY2025 (Dec). CEO Seth Blackley was paid $14.2M of that.
| Name | |||
|---|---|---|---|
| Seth BlackleyChief Executive Officer | |||
| Daniel McCarthyPresident | |||
| John JohnsonFormer Chief Financial Officer; Chief Strategy Officer | |||
| Jonathan WeinbergGeneral Counsel | |||
| Emily RaffertyFormer Chief Operating Officer; EVP, Customer Success |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Evolent Health. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board6
See all- Peter GruaDirector · 5 yr on the boardIndependentCompensation (Chair)—Paid as an executive
- Kim KeckDirector · 4 yr on the boardIndependentAudit (Chair), Nominating and Governance—Paid as an executive
- Toyin AjayiDirector · 2 yr on the boardIndependentCompliance and Regulatory Affairs, Strategy—Paid as an executive
- Russell GlassDirector · 1 yr on the boardIndependentCompliance and Regulatory Affairs, Nominating and Governance—Paid as an executive
- Jill SmithDirector · 0 yr on the boardIndependent—Paid as an executive
- Shawn GuertinDirector · 0 yr on the boardIndependentAudit—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 24, 2026 | FY2025 |
| Annual report | 10-K | Feb 25, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 25, 2025 | FY2024 |
| Annual report | 10-K | Feb 21, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Feb 23, 2024 | FY2023 |
